Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,General Medicine
Reference75 articles.
1. Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., and Layward, L. (2000). Cannabinoids control spasticity and tremor in a MS model. Nature 404:84–87.
2. Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T., and Di Marzo, V. (2001). Endocannabinoids control spasticity in a MS model. FASEB J. 15:300–302.
3. Brotchie, J. M., Fox, S. H., and Henry, B. (1997). The cannabinoid receptor antagonist SR 141716A reduces L-dopa-induced dyskinesia in the MPTP-treated primate model of Parkinson's disease. Br. J. Pharmacol. 123:67–76.
4. Brotchie, J. M. (2003). CB1 cannabinoid receptor signalling in Parkinson's disease. Curr. Opin. Pharmacol. 3:54–61.
5. Carroll, C. B., Bain, P. G., Teare, L., Liu, X., Joint, C., Wroath, C., Parkin, S. G., Fox, P., Wright, D., Hobart, C., and Zajicek, P. (2004). Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study. Neurology 63(7):1245–1250.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献